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SHORT COMMUNICATION
Noonan syndrome (NS) is an autosomal dominant disor-
der with a frequency of 1/1,000 to 1/2,500 live births (1, 
2). The symptoms of NS include short stature, specific 
facial features such as hypertelorism and posteriorly 
rotated ears, epicanthal folds, congenital heart failure, 
and webbed neck. Although skin tumours are not com-
mon features in patients with NS, several cases of NS 
with multiple granular cell tumours in the skin have been 
reported (3). 
Thus far, heterozygous mutations in 9 genes have 
been documented to underlie this disorder, and ap-
proximately 75% of patients clinically diagnosed with 
NS harbour a mutation in those genes (2). It has been 
revealed that the genes involved in NS are regulators 
of rat sarcoma viral oncogene (RAS)-mitogen-activated 
protein kinase (MAPK) pathways, especially the RAS-
ERK pathway, which plays a crucial role in various 
physiological processes, such as cell proliferation, sur-
vival and differentiation (4). Since gene mutations in NS 
are gain-of-function mutations, it has been suggested 
that activation of the RAS-MAPK signalling pathway 
might be involved in the development of NS. However, 
whether and how such activation is involved in the 
clinical symptoms of NS remains unclear. We report 
here a case of NS with atypical multiple subcutaneous 
tumours with RAS-MAPK activation. 
CASE REPORTS
A 2-year-old girl diagnosed with NS was referred to our derma-
tology department for evaluation of multiple skin nodules on her 
trunk. The patient had been clinically diagnosed with NS based 
on congenital heart failure and several congenital anomalies, 
such as webbed neck and epicanthal folds. Cutaneous nodules 
were detected at birth, and their number and size had increased 
gradually with age. On examination, the patient exhibited 
multiple skin-coloured nodules on her lower abdomen (Fig. 
1a). Some café-au-lait spot-like pigmented macules were also 
detected on her abdomen and back (Fig. 1a and b). Histological 
analysis of the nodules revealed hyperplasia of fibroblast-like 
spindle cells in the lower dermis (Fig. 1c and d). No granular 
cell tumour-like cells, which have a granular appearance in 
the cytoplasm, were observed. To characterize the nature of 
the tumour cells in more detail, immunohistochemical analysis 
was performed using anti-smooth muscle actin, S-100, desmin, 
β-catenin, CD68, factor XIIIa, and CD34 antibodies. However, 
no positive signals were detected in the tumours with the above 
antibodies (data not shown), suggesting that the tumour cells 
are mesenchymal in origin and composed mainly of fibroblasts.
To investigate whether activation of the RAS-MAPK signal-
ling pathway was involved in the tumour formation, further 
immunohistochemical analysis of the tumour was performed. 
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Fig. 1. Clinical symptoms and histology 
of subcutaneous tumours. (a) Multiple 
subcutaneous tumours on the lower abdomen. 
(b) Café-au-lait spot-like pigmented macules 
on the back. (c) Low magnification view (4×) 
of haematoxylin and eosin-stained section. 
Fibrous structures are detected in the lower 
dermis and fat tissues. The square indicates 
the region selected for high-magnification 
view. (d) High-magnification view (100×) 
in (c). Hyperplasia of fibroblast-like spindle 
cells is detected among the collagen fibres. 
Written consent to publish was obtained from 
the patient.
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Phosphorylation of 3 MAPK, i.e. extracellular signal-regulated 
kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 MAPK, 
was examined. Positive signals for phosphorylated (p)-ERK and 
p-p38 MAPK were clearly detected in the cytoplasm of tumour 
cells (Fig. 2 a–c), indicating that both ERK and p38 MAPK are 
activated in the tumour cells. On the other hand, no positive 
signals for p-JNK were detected (Fig. 2d). 
DISCUSSION
NS is one of the syndromes called neuro-cardio-facial-
cutaneous syndromes (NCFC), which include several dis-
orders, such as Noonan, neurofibromatosis type 1 (NF1), 
LEOPARD, Costello and cardiofaciocutaneous syndrome 
(1). Germline mutations in genes coding for different 
components of the RAS-MAPK signalling have been 
recognized as the cause of NCFC (1). It has been reported 
that NCFC sometimes develop multiple subcutaneous 
tumours, such as neurofibroma in NF1 (1, 2) and granular 
cell tumours in NS (3), but histological characteristics 
of the tumours in the current case did not correspond to 
those of such tumours. In addition, desmoid tumours (5), 
dermatofibroma, and dermatofibrosarcoma protuberans 
were other possible differential diagnoses, but the results 
obtained from the immunohistochemical analysis did not 
support such diagnoses. Taken together, the tumour cells 
seem to be of mesenchymal origin and composed mainly 
of fibroblasts. As far as we have examined, we were not 
able to find similar NS cases that manifest fibroblastic 
tumours as observed in the current case. In addition, 
the patient exhibited café-au-lait spot-like pigmented 
macules, which is also an atypical feature in NS (1, 2). 
The gene mutations in NS are gain-of-function mu-
tations; therefore, various clinical symptoms in NS, 
including skin tumours, may be caused by aberrant 
activation of the RAS-MAPK pathway (1, 2). However, 
direct evidence of the association between RAS-MAPK 
activation and the clinical symptoms of NS remains 
unclear. In the case reported here we clearly observed 
ERK activation in the tumours, which may provide 
evidence of the involvement of RAS-MAPK activation 
for clinical symptoms in NS. In addition to ERK, p38 
MAPK activation was observed in the present case. 
Because all known gene mutations in NS are regula-
tors of the RAS-ERK pathway (1, 2) but not the p38 
MAPK pathway, our patient may have some new or 
additional mutations in unknown molecules other than 
ERK pathway, which might lead to the development 
of the multiple subcutaneous tumors with ERK/p38 
activation.
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Fig. 2. Immunohistochemical analysis for various 
mitogen-activated protein kinase (MAPK) in the 
subcutaneous tumour cells. (a) Haematoxylin and 
eosin (HE) staining for the subcutaneous tumours. 
Immunohistochemical analysis for (b) phosphorylated 
extracellular signal-regulated kinase (p-ERK), (c) 
phosphorylated p38 MAPK (p-p38 MAPK), and (d) 
phosphorylated c-Jun N-terminal kinase (p-JNK). 
Brown signals indicate positive signals for each 
antibody. Original magnification 40×. 
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